Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Boucher

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Viruses|September 5, 2020
Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDACynthia Lungu, Francesco A Procopio, Ronald J Overmars, et al.
Plos Pathogens|October 8, 2011
Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferretsErhard van der Vries, Edwin J Veldhuis Kroeze, Koert J Stittelaar, et al.
Plos One|March 7, 2009
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 updateDiane E Bennett, Ricardo J Camacho, Dan Otelea, et al.
The Journal of Clinical Investigation|November 22, 2000
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesS M Clee, J J Kastelein, M van Dam, et al.
Viruses|January 22, 2022
The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral FailuresStephanie Popping, Valeria Cento, Carole Seguin-Devaux, et al.
Plos Medicine|January 18, 2007
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanismMonique Nijhuis, Noortje M van Maarseveen, Stephane Lastere, et al.
Lancet (London, England)|October 26, 1999
Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol effluxM Marcil, A Brooks-Wilson, S M Clee, et al.
The Journal of Infectious Diseases|August 8, 2018
Reply to Darcis and BerkhoutIngeborg E A Wijting, Cynthia Lungu, Bart J A Rijnders, et al.
The Journal of Infectious Diseases|April 5, 2018
HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance MonotherapyIngeborg E A Wijting, Cynthia Lungu, Bart J A Rijnders, et al.
The Lancet. Infectious Diseases|March 25, 2011
European guidelines on the clinical management of HIV-1 tropism testingL P R Vandekerckhove, A M J Wensing, R Kaiser, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Viruses|September 5, 2020
Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDACynthia Lungu, Francesco A Procopio, Ronald J Overmars, et al.
Plos Pathogens|October 8, 2011
Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferretsErhard van der Vries, Edwin J Veldhuis Kroeze, Koert J Stittelaar, et al.
Plos One|March 7, 2009
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 updateDiane E Bennett, Ricardo J Camacho, Dan Otelea, et al.
The Journal of Clinical Investigation|November 22, 2000
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotesS M Clee, J J Kastelein, M van Dam, et al.
Viruses|January 22, 2022
The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral FailuresStephanie Popping, Valeria Cento, Carole Seguin-Devaux, et al.
Plos Medicine|January 18, 2007
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanismMonique Nijhuis, Noortje M van Maarseveen, Stephane Lastere, et al.
Lancet (London, England)|October 26, 1999
Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol effluxM Marcil, A Brooks-Wilson, S M Clee, et al.
The Journal of Infectious Diseases|August 8, 2018
Reply to Darcis and BerkhoutIngeborg E A Wijting, Cynthia Lungu, Bart J A Rijnders, et al.
The Journal of Infectious Diseases|April 5, 2018
HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance MonotherapyIngeborg E A Wijting, Cynthia Lungu, Bart J A Rijnders, et al.
The Lancet. Infectious Diseases|March 25, 2011
European guidelines on the clinical management of HIV-1 tropism testingL P R Vandekerckhove, A M J Wensing, R Kaiser, et al.
Pageof 18